Abstract
In involved psoriatic tissue, which is characterized by chronic inflammation in both epidermis and dermis, elevated levels of arachidonic acid and eicosanoids have been measured. This implies that a phospholipase A2 (PLA2) may be involved in the pathogenesis of psoriasis. The PLA2's are a group of enzymes that release unsaturated fatty acids from thesn2-position of membrane phospholipids. Once released, the fatty acids are converted by various enzymes into biologically very important signaling molecules. Release of arachidonate initiates the arachidonate cascade, leading to the synthesis of eicosanoids such as prostaglandins, thromboxanes, leukotrienes, and lipoxines. Eicosanoids are important in a variety of physiological processes and play a central role in inflammatory reactions and in intracellular signal transduction processes. Other important inflammatory mediators, such as lyso-PAF (a precursor for PAF) and other lysophospholipids, may also be formed through the action of a PLA2. We report for the first time the detection of transcripts of nonpancreatic phospholipase A2 (npPLA2, type II) and cytosolic (c) PLA2 in human skin, and overexpression of npPLA2 in involved skin from patients with psoriasis (plaque psoriasis and pustular psoriasis). Limited amounts of npPLA2 enzyme are detected immunologically in the uppermost layers of epidermis from healthy persons. Both involved and uninvolved psoriatic epidermis contain higher levels of npPLA2 than normal skin. Positive cells in dermis showed significantly higher levels of npPLA2 than epidermal cells. In dermis from healthy persons, only weak staining of a few cells could be detected. The two PLA2 enzymes detected in psoriatic skin (cytosolic and nonpancreatic) may both be involved in eicosanoid overproduction in psoriatic tissue, and the npPLA2 may also be involved in potentiating cell activation, especially T cells.
Similar content being viewed by others
References
Chang, E. Y., C. Hammerberg, G. Fisher, O. Baadsgaard, C. N. Ellis, J. J. Voorhees, andK. D. Cooper. 1992. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.Arch. Dermatol. 128:1479–1485.
Asaoka, Y., K. Yoshida, Y. Sasaki, Y. Nishizuka, M. Murakami, I. Kudo, andK. Inoue. 1993. Possible role of mammalian secretory group II phospholipase A2 in T-lymphocyte activation: Implication in propagation of inflammatory reaction.Proc. Natl. Acad. Sci. U.S.A. 90:176–719.
Murakami, M., I. Kudo, andK. Inoue. 1991. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2.FEBS Lett. 294:247–251.
Seilhammer, J. J., T. L. Randall, M. Yamanaka, andL. K. Johnson. 1986. Pancreatic phospholipase A2: Isolation of the gene and cDNAs from porcine pancreas and human lung.DNA 5:519–527.
Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, andR. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2.J. Biol. Chem. 264:5768–5775.
R. M. Kramer, E. F. Roberts, J. Manetta, andJ. E. Putnam. 1991. The Ca2+-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells.J. Biol. Chem. 266:5268–5272.
Pruzanski, W., andP. Vadas. 1991. Phospholipase A2—a mediator between proximal and distal effectors of inflammation.Immunol. Today 12:143–146.
Wery, J.-P., R. W. Schevitz, D. K. Clawson, J. L. Bobbitt, E. R. Dow, G. Gamboa, T. Goodson, R. B. Hermann, R. M. Kramer, D. B. McClure, E. D. Mihelich, J. E. Putnam, J. D. Sharp, D. H. Stark, C. Teater, M. W. Warrick, andN. D. Jones. 1991. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 Å resolution.Nature 352:79–82.
Scott, D. L., S. P. White, J. L. Browning, J. J. Rosa, M. H. Gelb, andP. B. Sigler. 1991. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.Science 254:1007–1010.
Voorhees, J. 1983. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.J. Arch. Dermatol. 119:541–547.
Kragballe, K., andJ. J. Vorhees. 1983. Arachidonic acid and leukotrienes in dermatology.J. Invest. Dermatol. 81:293–296.
Forster, S., E. Ilderton, J. F. B. Norris, R. Summerly, andH. J. Yardley. 1985. Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.Br. J. Dermatol. 112:135–147.
Greaves, M. W., andR. D. R. Camp. 1988. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: An integrated approach to inflammation of human skin.Arch. Dermatol. Res. 280:S33-S41.
Bergers, M., D. R. Verhagen, M. Jongerius, P. C. M. van de Kerkhof, andP. D. Mier. 1988. A unique phospholipase A2 in human epidermis: its physiologic function and its level in certain dermatoses.J. Invest. Dermatol. 90:23–25.
Hammarstrøm, S., M. Hamberg, B. Samuelsson, E. A. Duell, M. Stawiski, andJ. J. Voorhees. 1975. Increased concentrations of nonesterified arachidonic acid, 12-l-hydroxy-5,8,10,14-eicosatetraenoic acid, PGE2 and PGF2α in epidermis of psoriasis.Proc. Natl. Acad. Sci. U.S.A. 72:5130.
Chirgwin, J. M., A. E. Przybla, R. J. MacDonald, andW. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.J. Biochem. 18:5294–5299.
Wallner, B., R. J. Mattaliano, C. Hession, R. Cate, R. L. Tizard, L. K. Sinclair, C. W. Foeller, E. P. Chow, J. L. Browning, K. L. Ramachandran, andR. B. Pepinsky. 1986. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor, with potential antiinflammatory activity.Nature 320:77–81.
Feinberg, A. P., andB. Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.Anal. Biochem. 137:266–267.
Church, G.M., andW. Gilbert. 1984. Genomic sequencing.Proc. Natl. Acad. Sci. U.S.A. 81:1991–1995.
Herrmann, B., M. Bucan, P. E. Mains, A. M. Frischauf, L. M. Silver, andH. Lehrach. 1986. Genetic analysis of the proximal portion of the mouse + complex: Evidence for a second inversion within + haplotypes.Cell 44:469–476.
Stoner, C. R., L. M. Reik, M. Donohue, W. Levin, andR. M. Crowl. 1991. Human group II phospholipase A2: Characterization of monoclonal antibodies and immunochemical quantitation of the protein in synovial fluid.J. Immunol. Methods 145:127–136.
Crowl, R., C. Stoner, T. Stoller, Y.-C. Pan, andR. Conroy. 1990. Isolation and characterization of cDNA clones from human placenta coding for phospholipase A2.In Biochemistry, Molecular Biology and Physiology of Phospholipase A2 and its Regulatory Factors. A. B. Mukherjee, editor. Plenum Press, New York. 173–184.
Van Furth, R. 1982. Current view on the mononuclear phagocytic system.Immunobiology 161:178–187.
Johansen, B., R. M. Kramer, C. Hession, P. McGray, andR. B. Pepinsky. 1992. Expression, purification and biochemical comparison of natural and recombinant human nonpancreatic phospholipase A2.Biochem. Biophys. Res. Commun. 187:544–551.
van den Bosch, H., A. J. Aarsman, andA. J. Verkleij. 1989. Immunogold localization of phospholipase A2 in rat platelets.In Leukotrienes and Prostanoids in Health and Disease, Vol. 3. U. Zor, Z. Naor, and A. Danon, editors. Karger, Basel. 257–261.
Wright, G. C., J. Weiss, K. S. Kim, H. Verheij, andP. Elsbach. 1990. Bacterial phospholipid hydrolysis enhances the destruction ofEscherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases.J. Clin. Invest. 85:1925–1935.
Rosenbach, T., M. D. Janusz, J. Czernielewski, M. Hecker, andB. Czarnetzki. 1990. Comparison of eicosanoid generation by highly purified human langerhans cells and keratinocytes.J. Invest. Dermatol. 95:104–107.
Mayer, B., L. Rauter, E. Zenzmaier, H. Gleispach, andH. Esterbauer. 1984. Characterisation of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts.Biochim. Biophys. Acta 795:151–161.
Pruzanski, W., P. Vadas, andV. Fornasier. 1986. Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbits.J. Invest. Dermatol. 86:380–282.
Crowl, R. M., T. J. Stoller, R. R. Conroy, andC. R. Stoner. 1991. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.J. Biol. Chem. 266:2647–2651.
Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, D. N. Sauder, J. J. Voorhees, andG. Fisher. 1990. IL-1 activity is reduced in psoriatic skin; decreased IL-1α and increased nonfunctional IL-1β.J. Immunol. 144:4593–4603.
Oxholm, A., M. Diamant, P. Oxholm, andK. Bendtzen. 1991. Interleukin-6 and tumor necrosis factor-alpha are expressed by keratinocytes but not by Langerhans cells.APMIS 99:58–64.
Muhl, H., T. Geiger, W. Pignat, F. Marki, H. van den Bosch, N. Cerletti, D. Cox, G. McMaster, K. Vosbeck, andJ. Pfeilschifter. 1992. Transforming growth factors type-β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin-1 and forskolin in rat mesangial cells.FEBS Lett. 301:190–194.
Murakami, M., I. Kudo, andK. Inoue. 1993. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells.J. Biol. Chem. 268:839–844.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andersen, S., Sjursen, W., Lægreid, A. et al. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue. Inflammation 18, 1–12 (1994). https://doi.org/10.1007/BF01534593
Issue Date:
DOI: https://doi.org/10.1007/BF01534593